Pain Management News

Multidisciplinary strategies combining physical and psychological strategies were the most effective for patients with hypermobility spectrum disorders or Ehlers-Danlos syndrome, according to a systematic review.

The FDA has granted breakthrough therapy designation to PF614-MPAR, a “next-generation opioid” designed to limit oral overdose potential, according to a press release from its manufacturer.

The FDA has approved an abbreviated new drug application from ANI Pharmaceuticals for indomethacin oral suspension, a generic version of Indocin oral suspension, according to a press release from the manufacturer.

What should rheumatologists know about what we've learned about COVID-19 and long COVID in 2023? Hosted by Dr. Leonard Calabrese.

The state of pain management in rheumatology has always been in flux.

SAN DIEGO — The likelihood of opioid use among patients with autoimmune rheumatic disease has decreased annually by 15% since 2014, according to data presented at ACR Convergence 2023.

The FDA has advised consumers to exercise caution before using certain products promoted for arthritis and pain, as some have been found to contain hidden ingredients that may pose a significant health risk.

In a Healio video exclusive, Leonard Calabrese, DO, chief medical editor of Healio Rheumatology, offered his insights for our November issue, led by a cover story examining the connection between the gut microbiome and rheumatic disease.

CDC data show that 16.2% of pregnant women aged 18 to 44 years reported using marijuana nearly every day.

SAN DIEGO — Non-pharmacologic approaches to pain management in rheumatology, like exercise and meditation, can be superior to pharmacologic strategies, according to a speaker at the 2023 Congress of Clinical Rheumatology West.